Regeneron Completes Rolling BLA For IL-1 Trap In CAPS June 11, 2007 By Jennifer Boggs Hoping to introduce the first marketed product for a group of rare chronic inflammatory conditions, Regeneron Pharmaceuticals Inc. completed a rolling biologics license application for its interleukin-1 (IL-1) Trap. (BioWorld Today)Read More
RSS